Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8208 participants
INTERVENTIONAL
2018-03-14
2021-12-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outpatient Birth: Pilot Study
NCT03815227
Outpatient Induction of Labour Using a Double Balloon Transcervical Catheter in Low-risk Pregnant Women: a Two-centre Open Prospective Randomised Controlled Trial - OutCRIB
NCT07265518
Personalized Support Care in Alternative Midwifery Birth Units Versus Traditional Units in France : Effects on Perinatal Health and Outcomes
NCT05483101
Methods of Labor Induction and Perinatal Outcomes
NCT02477085
Patient Satisfaction During Physiological Water or Land Birth: a Prospective Study in an French Tertiary Maternity Unit.
NCT06441370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The expected benefits for the patients are a decrease in the maternal-fetal morbidity and mortality, an adapted orientation of the patient according to the foreseeable delay before delivery. This is to avoid the patient's referral to a maternity ward that is not her own when it is not necessary - that is, an orientation in a maternity ward that is inappropriate for her condition and / or with a risk of delivery outside maternity. Finally, another expected benefit is the patient delivery in the presence of a doctor and / or midwife.
The expected benefits for public health are an adapted sending of means, principle of the "just care" and the good use of the medical resources, to avoid the situations of deficiency of SMUR following an inappropriate sending (accessibility of the offer of care) and improved practices, without additional cost to public health (improve the efficiency of the UAS regulation - Center 15).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group SPIA
The regulator will be asked to systematically use the tool Predictor score of the imminence of a childbirth (SPIA). This tool is used to evaluate the means to be sent following a call for imminent delivery outside the hospital.
Predictor score of the imminence of a childbirth (SPIA)
The SPIA score is based on the analysis of 6 types of criteria: panic during the call, the possibility of having a telephone contact with the parturient, the urge to push and if so for how long, the rhythm of the CU, some aggravating factors (history of fast delivery or at home, maternal age between 26 and 35 years, lack of follow-up of pregnancy) and 2 minor factors (nulliparity and the taking of a tocolytic treatment). Each criteria is between 0 to 8, except for the 2 minor criteria for which 7 and 3 points are removed if they are present. This gives a score between -10 and +33, which is weighted according to the admission time estimated at the hospital (30 minutes, 1h and 2h).
Control group
The classic care will be made according to the usual practices of the doctor and the center.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Predictor score of the imminence of a childbirth (SPIA)
The SPIA score is based on the analysis of 6 types of criteria: panic during the call, the possibility of having a telephone contact with the parturient, the urge to push and if so for how long, the rhythm of the CU, some aggravating factors (history of fast delivery or at home, maternal age between 26 and 35 years, lack of follow-up of pregnancy) and 2 minor factors (nulliparity and the taking of a tocolytic treatment). Each criteria is between 0 to 8, except for the 2 minor criteria for which 7 and 3 points are removed if they are present. This gives a score between -10 and +33, which is weighted according to the admission time estimated at the hospital (30 minutes, 1h and 2h).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Calling the regulation of SAMU-Center 15 for start of work
* Patient not planning to give birth at home
* Delivery not having started at the time of the first call (hair, head, buttocks or feet not visible)
* Absence of a doctor, obstetrician or midwife on the spot during the call
* French language included (Patient and / or Near)
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital NOVO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Agnès RICARD-HIBON
Role: PRINCIPAL_INVESTIGATOR
Hôpital NOVO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier René-DUBOS
Cergy-Pontoise, Cergy-pontoise, France
Centre Hospitalier Universitaire d'Amiens
Amiens, , France
Centre Hospitalier Régional Universitaire de Besançon
Besançon, , France
Centre Hospitalier Universitaire Avicenne
Bobigny, , France
Hôpital Pellegrin
Bordeau, , France
Centre Hospitalier Henri Mondor
Créteil, , France
Centre Hospitalier Universitaire de Dijon
Dijon, , France
Centre Hospitalier Universitaire de Grenoble
Grenoble, , France
Hôpital André Mignot
Le Chesnay, , France
Centre Hospitalier Régional Universitaire de Lille
Lille, , France
Groupement Hospitalier Edouard Herriot
Lyon, , France
Centre Hospitalier Marc Jacquet
Melun, , France
Centre Hospitalier Régional Mets-Thionville
Metz, , France
Centre Hospitalier Annecy-Genevois
Metz-Tessy, , France
Centre Hospitalier Universitaire de Nancy
Nancy, , France
Centre Hospitalier Universitaire de Rennes
Rennes, , France
Centre Hospitalier Universitaire de la Réunion
Saint-Denis, , France
Centre Hospitalier de Toulon
Toulon, , France
Hôpital Purpan
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRD1616
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.